| 1 |
Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death [J]. Br Med Bull, 2009, 92: 7-32.
|
| 2 |
王亚楠, 吴思缈, 刘鸣. 中国脑卒中15年变化趋势和特点 [J]. 华西医学, 2021, 36(6): 803-807.
|
| 3 |
Guo Y, Peng Y, Zeng H, et al. Progress in mesenchymal stem cell therapy for ischemic stroke [J]. Stem Cells Int, 2021, 2021: 9923566.
|
| 4 |
Johnson J, Shojaee M, Mitchell Crow J, et al. From mesenchymal stromal cells to engineered extracellular vesicles: a new therapeutic paradigm [J]. Front Cell Dev Biol, 2021, 9: 705676.
|
| 5 |
Kapetanos K, Asimakopoulos D, Christodoulou N, et al. Chronological age affects MSC senescence in vitro-a systematic review [J]. Int J Mol Sci, 2021, 22(15): 7945.
|
| 6 |
Gancheva MR, Kremer KL, Gronthos S, et al. Using dental pulp stem cells for stroke therapy [J]. Front Neurol, 2019, 10: 422.
|
| 7 |
Wu T, Xu W, Chen H, et al. Comparison of the differentiation of dental pulp stem cells and periodontal ligament stem cells into neuron-like cells and their effects on focal cerebral ischemia [J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(9): 1016-1029.
|
| 8 |
Barzegar M, Wang Y, Eshaq RS, et al. Human placental mesenchymal stem cells improve stroke outcomes via extracellular vesicles-mediated preservation of cerebral blood flow [J]. EBioMedicine, 2021, 63: 103161.
|
| 9 |
Jin K, Sun Y, Xie L, et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat [J]. Neurobiol Dis, 2005, 18(2): 366-374.
|
| 10 |
Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect [J]. Stem Cells Dev, 2009, 18(5): 683-692.
|
| 11 |
Ishizaka S, Horie N, Satoh K, et al. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke [J]. Stroke, 2013, 44(3): 720-726.
|
| 12 |
Du S, Guan J, Mao G, et al. Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats [J]. Cell Transplant, 2014, 23 Suppl 1: S73-S82.
|
| 13 |
Lim JY, Jeong CH, Jun JA, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia [J]. Stem Cell Res Ther, 2011, 2(5): 38.
|
| 14 |
Li YH, Feng L, Zhang GX, et al. Intranasal delivery of stem cells as therapy for central nervous system disease [J]. Exp Mol Pathol, 2015, 98(2): 145-151.
|
| 15 |
Dabrowska S, Andrzejewska A, Lukomska B, et al. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles [J]. J Neuroinflammation, 2019, 16(1): 178.
|
| 16 |
Nakajima M, Nito C, Sowa K, et al. Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke [J]. Mol Ther Methods Clin Dev, 2017, 6: 102-111.
|
| 17 |
Oh SH, Choi C, Noh JE, et al. Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model [J]. Exp Mol Med, 2018, 50(4): 1-12.
|
| 18 |
Sarmah D, Kaur H, Saraf J, et al. Mitochondrial dysfunction in stroke: implications of stem cell therapy [J]. Transl Stroke Res, 2018. Online ahead of print.
|
| 19 |
Saraf J, Sarmah D, Vats K, et al. Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke [J]. Int J Neurosci, 2019, 129(10): 1039-1044.
|
| 20 |
He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha [J]. Cell, 2009, 137(6): 1100-1111.
|
| 21 |
Kong D, Zhu J, Liu Q, et al. Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy [J]. Cell Mol Neurobiol, 2017, 37(2): 303-313.
|
| 22 |
Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery [J]. Neurology, 2002, 59(4): 514-523.
|
| 23 |
Horita Y, Honmou O, Harada K, et al. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat [J]. J Neurosci Res, 2006, 84(7): 1495-1504.
|
| 24 |
Chen J, Li Y, Katakowski M, et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat [J]. J Neurosci Res, 2003, 73(6): 778-786.
|
| 25 |
Schäbitz WR, Steigleder T, Cooper-Kuhn CM, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis [J]. Stroke, 2007, 38(7): 2165-2172.
|
| 26 |
Nomura T, Honmou O, Harada K, et al. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat [J]. Neuroscience, 2005, 136(1): 161-169.
|
| 27 |
Gao Q, Li Y, Shen L, et al. Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro [J]. Neuroscience, 2008, 152(3): 646-655.
|
| 28 |
Shen LH, Li Y, Gao Q, et al. Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain [J]. Glia, 2008, 56(16): 1747-1754.
|
| 29 |
Shen LH, Li Y, Chen J, et al. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke [J]. Stroke, 2007, 38(7): 2150-2156.
|
| 30 |
Siconolfi LB, Seeds NW. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush [J]. J Neurosci, 2001, 21(12): 4348-4355.
|
| 31 |
Xin H, Li Y, Shen LH, et al. Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse [J]. PLoS One, 2010, 5(2): e9027.
|
| 32 |
Krupinski J, Kaluza J, Kumar P, et al. Role of angiogenesis in patients with cerebral ischemic stroke [J]. Stroke, 1994, 25(9): 1794-1798.
|
| 33 |
Toyama K, Honmou O, Harada K, et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia [J]. Exp Neurol, 2009, 216(1): 47-55.
|
| 34 |
Liu K, Guo L, Zhou Z, et al. Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke [J]. Microvasc Res, 2019, 123: 74-80.
|
| 35 |
Zhang Y, Ma L, Su Y, et al. Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro [J]. Brain Res, 2019, 1725: 146432.
|
| 36 |
Zhu J, Liu Q, Jiang Y, et al. Enhanced angiogenesis promoted by human umbilical mesenchymal stem cell transplantation in stroked mouse is Notch1 signaling associated [J]. Neuroscience, 2015, 290: 288-299.
|
| 37 |
Onda T, Honmou O, Harada K, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia [J]. J Cereb Blood Flow Metab, 2008, 28(2): 329-340.
|
| 38 |
Adibhatla RM, Hatcher JF. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies [J]. CNS Neurol Disord Drug Targets, 2008, 7(3): 243-253.
|
| 39 |
Schnoor M, Parkos CA. Disassembly of endothelial and epithelial junctions during leukocyte transmigration [J]. Front Biosci, 2008, 13: 6638-6652.
|
| 40 |
Cheng Z, Wang L, Qu M, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice [J]. J Neuroinflammation, 2018, 15(1): 135.
|
| 41 |
Moon GJ, Sung JH, Kim DH, et al. Application of mesenchymal stem cell-derived extracellular vesicles for stroke: biodistribution and microRNA study [J]. Transl Stroke Res, 2019, 10(5): 509-521.
|
| 42 |
Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance [J]. Mol Cancer, 2019, 18(1): 75.
|
| 43 |
Guo S, Perets N, Betzer O, et al. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury [J]. ACS Nano, 2019, 13(9): 10015-10028.
|
| 44 |
Zhao Y, Gan Y, Xu G, et al. MSCs-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing CysLT2R-ERK1/2 mediated microglia M1 polarization [J]. Neurochem Res, 2020, 45(5): 1180-1190.
|
| 45 |
Bueno C, Martínez-Morga M, García-Bernal D, et al. Differentiation of human adult-derived stem cells towards a neural lineage involves a dedifferentiation event prior to differentiation to neural phenotypes [J]. Sci Rep, 2021, 11(1): 12034.
|
| 46 |
Radhakrishnan S, Trentz OA, Reddy MS, et al. In vitro transdifferentiation of human adipose tissue-derived stem cells to neural lineage cells - a stage-specific incidence [J]. Adipocyte, 2019, 8(1): 164-177.
|
| 47 |
Zhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats [J]. Exp Neurol, 2002, 174(1): 11-20.
|
| 48 |
Vu Q, Xie K, Eckert M, et al. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke [J]. Neurology, 2014, 82(14): 1277-1286.
|
| 59 |
Savitz SI, Yavagal D, Rappard G, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (recover-stroke) [J]. Circulation, 2019, 139(2): 192-205.
|
| 50 |
Jaillard A, Hommel M, Moisan A, et al. Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial [J]. Transl Stroke Res, 2020, 11(5): 910-923.
|
| 51 |
Levy ML, Crawford JR, Dib N, et al. Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke [J]. Stroke, 2019, 50(10): 2835-2841.
|
| 52 |
Steinberg GK, Kondziolka D, Wechsler LR, et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study [J]. J Neurosurg, 2018: 1-11.
|
| 53 |
Satani N, Cai C, Giridhar K, et al. World-wide efficacy of bone marrow derived mesenchymal stromal cells in preclinical ischemic stroke models: systematic review and meta-analysis [J]. Front Neurol, 2019, 10: 405.
|